A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine
Completed · Phase 1
Conditions studied: Pain
In brief
The purpose of this study is to evaluate the pharmacokinetics (PK) of suzetrigine (SUZ; VX-548) and its metabolite along with its safety and tolerability, in healthy participants.
Key facts
- Study ID
- NCT06336096
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 48
- Starts
- 2024-03-28
- Expected to finish
- 2024-06-19
- Last updated by the study team
- 2024-07-19
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Celerion - Tempe — Tempe, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.